behavior/neurological
• staggering; onset at approximately one year of age; progressive
|
• at 12 months of age, impairment was observed in a rotarod test and a balance beam test
|
muscle
• at 12 months of age, evoked compound action potential amplitudes were significantly reduced; the conduction velocity was unaffected
|
nervous system
• impaired vesicle transport in peripheral nerves
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
Charcot-Marie-Tooth disease type 2A1 | DOID:0110154 |
OMIM:118210 |
J:69772 |